(Q36698662)

15 August 2017

1 reference

title

The challenge of overactive bladder therapy: alternative to antimuscarinic agents (English)

1 reference

15 August 2017

Massimo Lazzeri

1

1 reference

15 August 2017

Michele Spinelli

series ordinal

2

1 reference

15 August 2017

publication date

1 November 2006

1 reference

International Brazilian Journal of Urology

15 August 2017

published in

1 reference

15 August 2017

volume

32

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

620-630

1 reference

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Brain responses to changes in bladder volume and urge to void in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

The sensory-efferent function of capsaicin-sensitive sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Role of the urothelium in bladder function

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

The role of neuropeptides in the regulation of the micturition reflex

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

The capsaicin receptor: a heat-activated ion channel in the pain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Bladder and cutaneous sensory neurons of the rat express different functional P2X receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Immunohistochemical evidence of vanilloid receptor 1 in normal human urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Cerebral control of bladder function

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Alpha1-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Effects of intrathecal injection of tamsulosin and naftopidil, alpha-1A and -1D adrenergic receptor antagonists, on bladder activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Usefulness of tamsulosin hydrochloride and naftopidil in patients with urinary disturbances caused by benign prostatic hyperplasia: a comparative, randomized, two-drug crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Comparison of tamsulosin and naftopidil for efficacy and safety in the treatment of benign prostatic hyperplasia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Actions of tramadol on micturition in awake, freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Tramadol inhibits rat detrusor overactivity caused by dopamine receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Intravesical capsaicin in patients with detrusor hyper-reflexia--a placebo-controlled cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Intravesical vanilloids and neurogenic incontinence: ten years experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Effectiveness of intravesical resiniferatoxin in treating detrusor hyper‐reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: a randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Botulinum toxin in urology: evaluation using an evidence-based medicine approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Botulinal neurotoxins: revival of an old killer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382006000600002

10.1590/S1677-55382006000600002

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference